Management of antipsychotic-related weight gain
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Despite variations across individuals and agents, antipsychotics are associated with clearly documented weight gain and adverse metabolic effects. Although increased appetite/caloric intake and various receptors, hormones and peptides have been implicated, biological mechanisms contributing to the increase in weight and glucose and lipid abnormalities with antipsychotics are largely unknown. This has hampered the creation of antipsychotics that are free of cardiometabolic effects, even in antipsychotic-naive/early-phase patients, as well as the development of strategies that can prevent or drastically diminish the adverse cardiometabolic effects. In general, three strategies can reduce the cardiometabolic risk of antipsychotics: switching to a less orexigenic/metabolically adverse antipsychotic; adjunctive behavioral treatments; and adjunctive pharmacologic interventions. However, each of these strategies has only been shown to be modestly effective. Among different behavioral interventions (N = 14, n = 746), group and individual treatment, dietary counseling and cognitive-behavioral therapy seem to be similarly effective. Among 15 different pharmacologic strategies (N = 35, n = 1629), only metformin, fenfluramine, sibutramine, topiramate and reboxetine were more effective than placebo, with the most evidence being available for metformin, and no head-to-head trials comparing individual pharmacologic interventions. However, even in the most successful trials the risk reduction was modest. Weight was not decreased to a pretreatment level, and despite superiority compared with placebo, weight gain still often occurred, particularly in antipsychotic-naive patients and when interventions were 'preventively' coinitiated with antipsychotics. Future research should focus on combining treatment modalities or agents and on exploring novel mechanism-based interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Self-citationTwenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436
Research works printed but not linked: 161
- 10.1377/hlthaff.28.5.w822 · DOI · Paper page
- 10.1016/S0920-9964(02)00498-X · DOI · Paper page
- Allison, 2003, Psychiatr. Serv., 54, 565, 10.1176/appi.ps.54.4.565 · DOI · Paper page
- 10.2165/00023210-200519001-00001 · DOI · Paper page
- 10.4088/JCP.v65n0219 · DOI · Paper page
- Kinon, 2005, J. Clin. Psychopharmacol., 25, 255, 10.1097/01.jcp.0000161501.65890.22 · DOI · Paper page
- 10.1016/S0140-6736(08)60486-9 · DOI · Paper page
- Ratzoni, 2002, J. Am. Acad. Child Adolesc. Psychiatry, 41, 337, 10.1097/00004583-200203000-00014 · DOI · Paper page
- 10.1176/appi.ajp.2008.08050756 · DOI · Paper page
- 10.1097/01.jcp.0000130558.86125.5b · DOI · Paper page
- Basson, 2001, J. Clin. Psychiatry, 62, 231, 10.4088/JCP.v62n0404 · DOI · Paper page
- Gebhardt, 2009, J. Psychiatr. Res., 43, 620, 10.1016/j.jpsychires.2008.11.001 · DOI · Paper page
- Lane, 2003, J. Clin. Psychiatry, 64, 316, 10.4088/JCP.v64n0314 · DOI
- 10.1097/01.jcp.0000203196.65710.2b · DOI
- Wetterling, 1999, J. Clin. Psychopharmacol., 19, 316, 10.1097/00004714-199908000-00006 · DOI
- Calarge, 2009, J. Child Adolesc. Psychopharmacol., 19, 101, 10.1089/cap.2008.007 · DOI · Paper page
- Neovius, 2007, Acta Psychiatr. Scand., 115, 277, 10.1111/j.1600-0447.2006.00899.x · DOI
- Weiss, 2009, J. Child Adolesc. Psychopharmacol., 19, 575, 10.1089/cap.2009.0050 · DOI · Paper page
- Correll, 2007, J. Am. Acad. Child Adolesc. Psychiatry, 46, 687, 10.1097/chi.0b013e318040b25f · DOI · Paper page
- Strassnig, 2007, Schizophr. Res., 93, 90, 10.1016/j.schres.2007.02.024 · DOI
- Gentile, 2009, Obes. Rev., 10, 527, 10.1111/j.1467-789X.2009.00589.x · DOI · Paper page
- Hummer, 1995, Eur. Neuropsychopharmacol., 5, 437, 10.1016/0924-977X(95)80001-I · doi:10.1016/0924-977x(95)80001-i
- Lee, 2004, J. Clin. Psychiatry, 65, 864, 10.4088/JCP.v65n0620 · DOI
- Saddichha, 2008, Schizophr. Res., 101, 266, 10.1016/j.schres.2008.01.004 · DOI
- 10.1016/j.psychres.2008.10.007 · DOI
- Lipkovich, 2008, BMC Psychiatry, 8, 78, 10.1186/1471-244X-8-78 · DOI
- Stauffer, 2009, BMC Psychiatry, 9, 12, 10.1186/1471-244X-9-12 · DOI
- Hennen, 2004, J. Clin. Psychiatry, 65, 1679, 10.4088/JCP.v65n1214 · DOI
- Simon, 2009, J. Clin. Psychiatry, 70, 1041, 10.4088/JCP.08r04392 · DOI · Paper page
- Reaven, 2009, J. Psychiatr. Res., 43, 997, 10.1016/j.jpsychires.2009.01.010 · DOI
- Ader, 2008, J. Psychiatr. Res., 42, 1076, 10.1016/j.jpsychires.2008.01.004 · DOI
- Houseknecht, 2007, Neuropsychopharmacology, 32, 289, 10.1038/sj.npp.1301209 · DOI · Paper page
- Mukherjee, 1989, Lancet, 1, 495, 10.1016/S0140-6736(89)91392-5 · DOI · Paper page
- Cohn, 2006, Can. J. Psychiatry, 51, 382, 10.1177/070674370605100608 · DOI
- Ryan, 2003, Am. J. Psychiatry, 160, 284, 10.1176/appi.ajp.160.2.284 · DOI · Paper page
- Spelman, 2007, Diabet. Med., 24, 481, 10.1111/j.1464-5491.2007.02092.x · DOI · Paper page
- Verma, 2009, J. Clin. Psychiatry, 70, 997, 10.4088/JCP.08m04508 · DOI
- Fernandez-Egea, 2009, Br. J. Psychiatry, 194, 434, 10.1192/bjp.bp.108.052605 · DOI · Paper page
- Meyer, 2009, Acta Psychiatr. Scand., 119, 4, 10.1111/j.1600-0447.2008.01317.x · DOI · Paper page
- 10.1016/j.schres.2005.07.014 · DOI · Paper page
- De Hert, 2006, Clin. Pract. Epidemiol. Ment. Health, 2, 14, 10.1186/1745-0179-2-14 · DOI
- Colton, 2006, Prev. Chronic Dis., 3, A42
- De Hert, 2009, Schizophr. Res., 117, 68, 10.1016/j.schres.2009.12.029 · DOI
- Arjona, 2004, Behav. Brain Res., 152, 121
- Gothelf, 2002, Am. J. Psychiatry, 159, 1055, 10.1176/appi.ajp.159.6.1055 · DOI · Paper page
- Graham, 2005, Am. J. Psychiatry, 162, 118, 10.1176/appi.ajp.162.1.118 · DOI · Paper page
- Zurlo, 1990, Am. J. Physiol., 259, E650
- Sharpe, 2006, Aust. N Z J. Psychiatry, 40, 810, 10.1080/j.1440-1614.2006.01888.x · DOI · Paper page
- Correll, 2004, Psychopharmacology (Berl.), 174, 477, 10.1007/s00213-004-1949-9 · DOI
- Sentissi, 2009, Int. Clin. Psychopharmacol., 24, 257, 10.1097/YIC.0b013e32832b6bf6 · DOI
- Ota, 2002, Clin. Exp. Pharmacol. Physiol., 29, 980, 10.1046/j.1440-1681.2002.t01-1-03755.x · DOI
- 10.1038/sj.npp.1300327 · DOI · Paper page
- 10.1097/00004583-200212000-00015 · DOI
- Newcomer, 2002, Arch. Gen. Psychiatry, 59, 337, 10.1001/archpsyc.59.4.337 · DOI · Paper page
- Henderson, 2005, Arch. Gen. Psychiatry, 62, 19, 10.1001/archpsyc.62.1.19 · DOI · Paper page
- Johnson, 2005, Diabetes, 54, 1552, 10.2337/diabetes.54.5.1552 · DOI · Paper page
- Reynolds, 2010, Pharmacol. Ther., 125, 169, 10.1016/j.pharmthera.2009.10.010 · DOI · Paper page
- Bai, 2009, Schizophr. Res., 111, 1, 10.1016/j.schres.2009.03.014 · DOI
- Maayan, 2010, Hum. Psychopharmacol., 25, 133, 10.1002/hup.1097 · DOI
- Haupt, 2005, Neuropsychopharmacology, 30, 184, 10.1038/sj.npp.1300563 · DOI
- Zhang, 2004, Br. J. Psychiatry, 184, 58, 10.1192/bjp.184.1.58 · DOI · Paper page
- Deng, 2010, Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 1, 10.1016/j.pnpbp.2009.11.009 · DOI
- 10.1038/sj.npp.1300027 · DOI · Paper page
- Kim, 2007, Proc. Natl Acad. Sci. USA, 104, 3456, 10.1073/pnas.0611417104 · DOI · Paper page
- 10.1016/j.pnpbp.2005.03.019 · DOI
- Mulder, 2007, Pharmacogenomics J., 7, 318, 10.1038/sj.tpj.6500422 · DOI
- De Luca, 2007, Hum. Psychopharmacol., 22, 463, 10.1002/hup.868 · DOI
- Templeman, 2005, Pharmacogenet. Genomics, 15, 195, 10.1097/01213011-200504000-00002 · DOI · Paper page
- Souza, 2008, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1848, 10.1016/j.pnpbp.2008.08.014 · DOI
- Siffert, 1999, J. Am. Soc. Nephrol., 10, 1921, 10.1681/ASN.V1091921 · DOI · Paper page
- Lencz, 2009, Dialogues Clin. Neurosci., 11, 405, 10.31887/DCNS.2009.11.4/tlencz · DOI
- Tiwari, 2010, Neuropsychopharmacology, 35, 1315, 10.1038/npp.2009.235 · DOI
- Liu, 2010, Pharmacogenomics J., 10, 30, 10.1038/tpj.2009.55 · DOI
- 10.4088/JCP.0508e14 · DOI
- Pae, 2009, Eur. Neuropsychopharmacol., 19, 562, 10.1016/j.euroneuro.2009.04.002 · DOI
- Ganguli, 2008, BMC Med., 6, 17, 10.1186/1741-7015-6-17 · DOI
- Essock, 2006, Am. J. Psychiatry, 163, 2090, 10.1176/ajp.2006.163.12.2090 · DOI · Paper page
- Rosenheck, 2009, Schizophr. Res., 107, 22, 10.1016/j.schres.2008.09.031 · DOI · Paper page
- De Hert, 2007, Schizophr. Bull., 33, 823, 10.1093/schbul/sbl037 · DOI
- 10.1016/j.schres.2007.12.487 · DOI · Paper page
- Meyer, 2005, Clin. Ther., 27, 1930, 10.1016/j.clinthera.2005.12.005 · DOI
- 10.4088/JCP.v69n0702 · DOI · Paper page
- 10.1016/j.schres.2008.09.002 · DOI · Paper page
- Lin, 2009, J. Clin. Psychopharmacol., 29, 529, 10.1097/JCP.0b013e3181bf613e · DOI
- Ried, 2009, J. Am. Pharm. Assoc., 49, 223, 10.1331/JAPhA.2009.08151 · DOI
- Weiden, 2008, Neuropsychopharmacology, 33, 985, 10.1038/sj.npp.1301482 · DOI
- Casey, 2003, Psychopharmacology (Berl.), 166, 391, 10.1007/s00213-002-1344-3 · DOI · Paper page
- Montes, 2007, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 383, 10.1016/j.pnpbp.2006.10.002 · DOI
- 10.1192/bjp.bp.107.042853 · DOI · Paper page
- Gabriele, 2009, Obes. Rev., 10, 442, 10.1111/j.1467-789X.2009.00570.x · DOI · Paper page
- Alvarez-Jimenez, 2006, J. Clin. Psychiatry, 67, 1253, 10.4088/JCP.v67n0812 · DOI · Paper page
- 10.1542/peds.2008-3727 · DOI · Paper page
- 10.1001/jama.264.19.2519 · doi:10.1001/jama.264.19.2519
- Johnston, 2007, J. Pediatr. Psychol., 32, 106, 10.1093/jpepsy/jsl010 · DOI
- 10.1097/01.chi.0000220851.94392.30 · DOI · Paper page
- Faulkner, 2007, Schizophr. Bull., 33, 654, 10.1093/schbul/sbm022 · DOI · Paper page
- Baptista, 2008, CNS Drugs, 22, 477, 10.2165/00023210-200822060-00003 · DOI
- Maayan, 2010, Neuropsychopharmacology, 35, 1520, 10.1038/npp.2010.21 · DOI · Paper page
- Baptista, 2006, Can. J. Psychiatry, 51, 192, 10.1177/070674370605100310 · DOI · Paper page
- Baptista, 2007, Schizophr. Res., 93, 99, 10.1016/j.schres.2007.03.029 · DOI
- Carrizo, 2009, Schizophr. Res., 113, 19, 10.1016/j.schres.2009.05.007 · DOI
- Wu, 2008, Am. J. Psychiatry, 165, 352, 10.1176/appi.ajp.2007.07010079 · DOI · Paper page
- Arman, 2008, Saudi Med. J., 29, 1130
- Klein, 2006, Am. J. Psychiatry, 163, 2072, 10.1176/ajp.2006.163.12.2072 · DOI · Paper page
- Citrome, 2008, Acta Psychiatr. Scand., 117, 412, 10.1111/j.1600-0447.2008.01194.x · DOI · Paper page
- 10.1016/j.braindev.2004.06.006 · DOI
- Roerig, 2009, Biol. Psychiatry, 65, 607, 10.1016/j.biopsych.2008.10.037 · DOI
- Gross, 2009, Adv. Ther., 26, 959, 10.1007/s12325-009-0070-1 · DOI
- Gross, 2010, Obesity (Silver Spring)
- 10.1001/jama.295.7.761 · DOI · Paper page
- Chakrabarti, 2009, Expert Opin. Ther. Targets, 13, 195, 10.1517/14728220802637063 · DOI
- Baptista, 2008, Psychiatry Res., 159, 250, 10.1016/j.psychres.2008.01.011 · DOI
- 10.4088/JCP.v65n0219 · DOI · Paper page
- 10.1093/schbul/ sbm038 · doi:10.1093/schbul/
- 10.1176/appi.ajp.2008.08030383 · DOI · Paper page
- Morrato, 2009, J. Clin. Psychopharmacol., 29, 26, 10.1097/JCP.0b013e31819294cb · DOI
- Morrato, 2010, Arch. Gen. Psychiatry, 67, 17, 10.1001/archgenpsychiatry.2009.179 · DOI · Paper page
- Morrato, 2008, J. Clin. Psychiatry, 69, 316, 10.4088/JCP.v69n0219 · DOI · Paper page
- 10.2337/dc08–1720 · DOI · Paper page
- Morrato, 2010, Arch. Pediatr. Adolesc. Med., 164, 344, 10.1001/archpediatrics.2010.48 · DOI · Paper page
- Le Foll, 2009, Psychopharmacology (Berl.), 205, 171, 10.1007/s00213-009-1506-7 · DOI · Paper page
- 10.4088/JCP.v66n0208 · DOI · Paper page
- Khazaal, 2007, Schizophr. Res., 91, 169, 10.1016/j.schres.2006.12.025 · DOI · Paper page
- Kwon, 2006, J. Clin. Psychiatry, 67, 547, 10.4088/JCP.v67n0405 · DOI · Paper page
- 10.1016/j.schres.2006.05.010 · DOI · Paper page
- 10.1016/j.schres.2006.01.008 · DOI
- 10.1080/00048670701689428 · DOI · Paper page
- Milano, 2007, Adv. Ther., 24, 123, 10.1007/BF02850000 · DOI
- 10.1176/ps.2007.58.4.544 · doi:10.1176/ps.2007.58.4.544 · Paper page
- Mauri, 2008, Pharmacopsychiatry, 41, 17, 10.1055/s-2007-992148 · DOI · Paper page
- Scocco, 2006, Eat. Behav., 7, 115, 10.1016/j.eatbeh.2005.08.003 · DOI
- Alvarez-Jimenez, 2010, Schizophr. Res., 116, 16, 10.1016/j.schres.2009.10.012 · DOI
- Evans, 2005, Aust. N Z J. Psychiatry, 39, 479
- 10.1111/j.1547-5069.2003.00237.x · DOI · Paper page
- 10.1016/j.euroneuro.2004.03.005 · DOI
- Modell, 1965, JAMA, 193, 275, 10.1001/jama.1965.03090040019006 · doi:10.1001/jama.1965.03090040019006
- Goodall, 1988, Br. J. Psychiatry, 153, 208, 10.1192/bjp.153.2.208 · DOI
- Bustillo, 2003, Neuropsychopharmacology, 28, 527, 10.1038/sj.npp.1300089 · DOI
- Assuncao, 2006, Rev. Bras. Psiquiatr., 28, 270, 10.1590/S1516-44462006000400005 · doi:10.1590/s1516-44462006000400005
- Atmaca, 2003, Hum. Psychopharmacol., 18, 457, 10.1002/hup.514 · DOI
- Atmaca, 2004, Hum. Psychopharmacol., 19, 37, 10.1002/hup.477 · DOI
- Joffe, 2008, J. Clin. Psychiatry, 69, 706, 10.4088/JCP.v69n0503 · DOI · Paper page
- Borovicka, 2002, J. Clin. Psychiatry, 63, 345, 10.4088/JCP.v63n0412 · doi:10.4088/jcp.v63n0412
- Baptista, 2009, Pharmacopsychiatry, 42, 14, 10.1055/s-0028-1085438 · DOI
- Henderson, 2009, Acta Psychiatr. Scand., 119, 457, 10.1111/j.1600-0447.2008.01325.x · DOI · Paper page
- Henderson, 2005, Am. J. Psychiatry, 162, 954, 10.1176/appi.ajp.162.5.954 · DOI
- Henderson, 2007, Acta Psychiatr. Scand., 115, 101, 10.1111/j.1600-0447.2006.00855.x · DOI
- Afshar, 2009, J. Psychopharmacol., 23, 157, 10.1177/0269881108089816 · DOI · Paper page
- Roy Chengappa, 2007, Bipolar Disord., 9, 609, 10.1111/j.1399-5618.2007.00506.x · DOI
- Ko, 2005, Clin. Neuropharmacol., 28, 169, 10.1097/01.wnf.0000172994.56028.c3 · DOI · Paper page
- Narula, 2010, Schizophr. Res., 118, 218, 10.1016/j.schres.2010.02.001 · DOI
- Nickel, 2005, J. Clin. Psychopharmacol., 25, 211, 10.1097/01.jcp.0000162806.46453.38 · DOI
- 10.1016/j.euroneuro.2003.10.004 · DOI
- 10.1176/appi.ajp.159.6.1058 · DOI
- Hinze-Selch, 2000, Psychopharmacology (Berl.), 149, 163, 10.1007/s002139900351 · DOI
- Lu, 2004, J. Clin. Psychiatry, 65, 766, 10.4088/JCP.v65n0607 · doi:10.4088/jcp.v65n0607
- Cavazzoni, 2003, Eur. Neuropsychopharmacol., 13, 81, 10.1016/S0924-977X(02)00127-X · DOI
- 10.1176/appi.ajp.160.2.297 · DOI · Paper page
- Poyurovsky, 2007, Psychopharmacology (Berl.), 192, 441, 10.1007/s00213-007-0731-1 · DOI
- Kim, 2006, Schizophr. Res., 82, 115, 10.1016/j.schres.2005.10.001 · DOI
- 10.1097/chi.0b013e31815b5cb1 · DOI · Paper page
Cited by
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Self-citationSolmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationAntipsychotic drugs and obesity
Correll, C. U., Lencz, T., & Malhotra, A. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.010 · Cited by 307
Self-citationWeight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
Manu, P., Dima, L., Shulman, M., Vancampfort, D., De Hert, M., & Correll, C. U. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12445 · Cited by 285
Self-citationMaayan, L., & Correll, C. U. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0015 · Cited by 252
Self-citationCaemmerer, J., Correll, C. U., & Maayan, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.017 · Cited by 182
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Libowitz, M. R., & Nurmi, E. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623681 · Cited by 99
A narrative review of the success of intramuscular gluteal injections and its impact in psychiatry
Soliman, E., Ranjan, S., Xu, T., Gee, C., Harker, A., Barrera, A., & Geddes, J. (2018) · Bio-Design and Manufacturing · doi:10.1007/s42242-018-0018-x · Cited by 61
Upadhyay, N., Patel, A., Chan, W., Aparasu, R. R., Ochoa-Perez, M., Sherer, J. T., Sanyal, S., & Chen, H. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.05.005 · Cited by 11
Torre, C. (2023) · London School of Economics and Political Science (LSE) · doi:10.21953/lse.00004557
Metadata
- Authors
- Maayan, L., & Correll, C. U.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2010-07
- Volume
- 10
- Issue
- 7
- Pages
- 1175-1200
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2167683515
- Cited by
- 128
- References
- 18
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.